Published on 6 Jan 2022 on Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours:
Illumina, Inc. (NASDAQ: ILMN) announced it has entered into a definitive co-development agreement with SomaLogic to bring the SomaScan Proteomics Assay onto Illumina's current and future high throughput next-generation sequencing platforms.